ISSN: 1940-6207

Journal Home

Journal Guideline

Cancer Prevention Research Q1 Unclaimed

American Association for Cancer Research Inc. United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Cancer Prevention Research is a journal indexed in SJR in Medicine (miscellaneous) and Oncology with an H index of 112. It has an SJR impact factor of 1,239 and it has a best quartile of Q1. It has an SJR impact factor of 1,239.

Cancer Prevention Research focuses its scope in these topics and keywords: cancer, carcinogenesis, inhibits, lg, growth, globally, genetic, genespathways, formation, esophagus, ...

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Medicine (miscellaneous) (Q1) Oncology (Q1) Cancer Research (Q2)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

1,239

SJR Impact factor

112

H Index

80

Total Docs (Last Year)

359

Total Docs (3 years)

2602

Total Refs

982

Total Cites (3 years)

322

Citable Docs (3 years)

2.58

Cites/Doc (2 years)

32.53

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Nature Biomedical Engineering Q1
Journal of Thoracic Oncology Q1
Annual Review of Clinical Psychology Q1
Lancet Digital Health, The Q1
Journal of Experimental Medicine Q1

Compare this journals

Aims and Scope

Best articles by citations

Metformin Use and Lung Cancer Risk--Letter

Viewing the Epigenetics of Colorectal Cancer through the Window of Folic Acid Effects

Estrogen Receptor Expression in Atypical Hyperplasia: Lack of Association with Breast Cancer

Robust In Vitro and In Vivo Neutralization against Multiple High-Risk HPV Types Induced by a Thermostable Thioredoxin-L2 Vaccine

Opportunities for the Primary Prevention of Colorectal Cancer in the United States

Activation of the PI3K/Akt/mTOR and MAPK Signaling Pathways in Response to Acute Solar-Simulated Light Exposure of Human Skin

Cancer Immunoprevention: A Case Report Raising the Possibility of "Immuno-interception"

Gonadal Tumor in Frasier Syndrome: A Review and Classification

Development and Validation of a Lung Cancer Risk Prediction Model for African-Americans

Failure Rates in the Hepatocellular Carcinoma Surveillance Process

Prevention of Skin Carcinogenesis by the -Blocker Carvedilol

CDB-4124, a Progesterone Receptor Modulator, Inhibits Mammary Carcinogenesis by Suppressing Cell Proliferation and Inducing Apoptosis

SHOW MORE ARTICLES

Enhanced Antitumor Activity of 3-Bromopyruvate in Combination with Rapamycin In Vivo and In Vitro

A Pilot Surrogate Endpoint Biomarker Study of Celecoxib in Oral Premalignant Lesions

Enhanced Antitumor Effects of Novel Intracellular Delivery of an Active Form of Menaquinone-4, Menahydroquinone-4, into Hepatocellular Carcinoma

Conceptualizing Health Behaviors as Acute Mood-Altering Agents: Implications for Cancer Control

A Pilot, First-in-Human, Pharmacokinetic Study of 9cUAB30 in Healthy Volunteers

Methylation-derived Neutrophil-to-Lymphocyte Ratio and Lung Cancer Risk in Heavy Smokers

Knowledge of Potential Harms and Benefits of Tamoxifen among Women Considering Breast Cancer Preventive Therapy

Chemoprevention Activity of 25-Hydroxyvitamin D in the MMTV-PyMT Mouse Model of Breast Cancer

Stabilization of Quercetin Paradoxically Reduces Its Proapoptotic Effect on UVB-Irradiated Human Keratinocytes

Inhibition by Resistant Starch of Red Meat-Induced Promutagenic Adducts in Mouse Colon

Chemoprevention of Human Actinic Keratoses by Topical DL- -tocopherol

Inhibition of Intestinal Polyp Formation by Pitavastatin, a HMG-CoA Reductase Inhibitor